arrow
J

Justin Call

utmd anderson cancer center
H指数:9
被引数:1,055

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer

首次人体I期临床试验,评估双特异性CD47抑制剂和CD40激动剂Fc融合蛋白SL-172154在铂耐药卵巢癌患者中的应用

2025-01-111
OA
NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors (Trial in Progress)
2024-10-010
PRE
Initial results from the phase I, first-in-human study of the covalent, PI3Kα inhibitor TOS-358 in patients with solid tumors, expressing PI3Kα mutations or amplifications

I期首个人体研究初步结果,该研究评估了共价PI3Kα抑制剂TOS-358在表达PI3Kα突变或扩增的实体瘤患者中的疗效。

2024-09-010
PRE
A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors
2023-04-1420
PRE